Kestra Private Wealth Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.02M | Buy |
46,711
+6,581
| +16% | +$707K | 0.07% | 275 |
|
|
2025
Q1 | $4.05M | Buy |
40,130
+6,977
| +21% | +$704K | 0.07% | 291 |
|
|
2024
Q4 | $2.96M | Buy |
33,153
+5,767
| +21% | +$515K | 0.05% | 340 |
|
|
2024
Q3 | $2.29M | Buy |
27,386
+1,911
| +8% | +$160K | 0.04% | 394 |
|
|
2024
Q2 | $1.96M | Buy |
25,475
+5,033
| +25% | +$388K | 0.04% | 401 |
|
|
2024
Q1 | $1.4M | Buy |
20,442
+1,872
| +10% | +$128K | 0.03% | 472 |
|
|
2023
Q4 | $1.07M | Buy |
18,570
+992
| +6% | +$57.3K | 0.03% | 508 |
|
|
2023
Q3 | $928K | Sell |
17,578
-53
| -0.3% | -$2.8K | 0.03% | 489 |
|
|
2023
Q2 | $954K | Buy |
17,631
+1,459
| +9% | +$78.9K | 0.03% | 457 |
|
|
2023
Q1 | $809K | Buy |
16,172
+2,736
| +20% | +$137K | 0.03% | 466 |
|
|
2022
Q4 | $622K | Sell |
13,436
-2,585
| -16% | -$120K | 0.03% | 470 |
|
|
2022
Q3 | $620K | Buy |
16,021
+2,446
| +18% | +$94.7K | 0.04% | 436 |
|
|
2022
Q2 | $506K | Buy |
13,575
+562
| +4% | +$20.9K | 0.03% | 502 |
|
|
2022
Q1 | $576K | Sell |
13,013
-1,261
| -9% | -$55.8K | 0.03% | 526 |
|
|
2021
Q4 | $606K | Sell |
14,274
-1,027
| -7% | -$43.6K | 0.03% | 527 |
|
|
2021
Q3 | $664K | Buy |
15,301
+1,928
| +14% | +$83.7K | 0.04% | 469 |
|
|
2021
Q2 | $572K | Buy |
13,373
+41
| +0.3% | +$1.75K | 0.03% | 477 |
|
|
2021
Q1 | $515K | Buy |
13,332
+5,522
| +71% | +$213K | 0.04% | 444 |
|
|
2020
Q4 | $278K | Buy |
7,810
+1,203
| +18% | +$42.8K | 0.02% | 576 |
|
|
2020
Q3 | $252K | Buy |
+6,607
| New | +$252K | 0.02% | 538 |
|